Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 12 May 2025 (earnings forecast) / 8 September 2025 (dividend forecast)The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Development projects related to contactless ICs, the medical field and government agencies have increased, and revenue is expected to exceed the plan. Profit is also expected to exceed the plan as a result. Based on the policy of targeting a payout ratio of 40%, the year-end dividend was increased because the net income forecast exceeded the previous forecast.
| Item | Details |
|---|---|
| Net Sales | ¥10,700 million → ¥11,220 million（+4.9%） |
| Operating profit | ¥1,840 million → ¥1,879 million（+2.1%） |
| Ordinary income | ¥2,010 million → ¥2,062 million（+2.6%） |
| Profit attributable to owners of the parent | ¥1,395 million → ¥1,509 million（+8.2%） |
| Net income per share | 136.76 yen and sen → 147.89 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 12 May 2025 (earnings forecast) / 8 September 2025 (dividend forecast) |
| Previous-period results | Fiscal year ended March 2025: revenue ¥10,295 million, operating profit ¥1,793 million, ordinary profit ¥1,893 million, net income ¥1,344 million, and net income per share ¥131.79 |
| Reason for the revision | Development projects related to contactless ICs, the medical field and government agencies have increased, and revenue is expected to exceed the plan. Profit is also expected to exceed the plan as a result. Based on the policy of targeting a payout ratio of 40%, the year-end dividend was increased because the net income forecast exceeded the previous forecast. |
| Dividend forecast revision | The year-end dividend has been increased by ¥4 per share and revised from ¥56 to ¥60. The annual dividend would be ¥120.00 if the stock split is not taken into account. |
| Consolidated / non-consolidated | Non-consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Development projects related to contactless ICs, the medical field and government agencies have increased, and revenue is now expected to exceed the plan. Profit is also expected to exceed the plan as a result, and the year-end dividend was increased in line with the policy of targeting a payout ratio of 40%.